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Aims This work investigates the role of myoglobin in mediating the vascular relaxation induced by nitrite. Nitrite, previously
considered an inert by-product of nitric oxide metabolism, is now believed to play an important role in several areas
of pharmacology and physiology. Myoglobin can act as a nitrite reductase in the heart, where it is plentiful, but it is
present at a far lower level in vascular smooth muscle—indeed, its existence in the vessel wall is controversial. Haem
proteins have been postulated to be important in nitrite-induced vasodilation, but the speciﬁc role of myoglobin is
unknown. The current study was designed to conﬁrm the presence of myoglobin in murine aortic tissue and to test
the hypothesis that vascular wall myoglobin is important for nitrite-induced vasodilation.
Methods
and results
Aortic rings from wild-type and myoglobin knockout mice were challenged with nitrite, before and after exposure to
the haem-protein inhibitor carbon monoxide (CO). CO inhibited vasodilation in wild-type rings but not in myoglo-
bin-deﬁcient rings. Restitution of myoglobin using a genetically modiﬁed adenovirus both increased vasodilation to
nitrite and reinstated the wild-type pattern of response to CO.
Conclusion Myoglobin is present in the murine vasculature and contributes signiﬁcantly to nitrite-induced vasodilation.
-----------------------------------------------------------------------------------------------------------------------------------------------------------
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1. Introduction
Nitric oxide, derived from endothelial nitric oxide synthase (eNOS),
acts as a paracrine regulator of vascular smooth muscle tone. Lumenal
diffusion of nitric oxide results in the production of a number of
metabolites including nitrite (NO2
2), which was previously considered
to have little vasoactive effect. However, it has recently become clear
that under certain circumstances, nitrite may be reduced back to nitric
oxide to elicit vasorelaxation
1,2 and confer protection against
ischaemia-reperfusion injury.
3–6 While there is an increasing appreci-
ation of the signiﬁcance of these pathways, controversy exists as to
whether they represent pharmacological or genuinely physiological
phenomena.
Under conditions of profound hypoxia and/or acidosis, the con-
version of nitrite to nitric oxide may occur spontaneously (via acid
disproportionation).
7 Under less extreme conditions, various factors
have been shown to be capable of facilitating nitrite reduction.
These include microsomal cytochrome P-450;
8,9 red cell and vascular
xanthine oxidase;
10 red cell and vascular eNOS, mitochondrial alde-
hyde oxidase (ALDH2);
10 neuroglobin;
11 haemoglobin;
12–18 and myo-
globin.
19 While all of these agents, alone and in combination, are
capable of facilitating nitrite reduction, their physiological role
remains unclear. In the heart, myoglobin is an important nitrite
reductase, and the potent protective effect of nitrite against
ischaemia-reperfusion injury seen in wild-type mice is absent in myo-
globin knockout mice.
20 Conversely, the role of myoglobin as a nitrite
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cardiac muscle but is present in very low concentrations in vascular
smooth muscle—indeed some studies have failed to demonstrate
its presence at all
21—so a priori myoglobin might be considered an
unlikely contributor to nitrite reductase activity in the vasculature.
The present study was therefore designed to assess the role of vascu-
lar smooth muscle myoglobin as a nitrite reductase during conditions
of minor (physiological) hypoxia.
2. Methods
2.1 Animals
Male NMRI and myo
2/2 mice were used at 6–7 weeks of age; Myo
2/2
mice were obtained from a breeding colony at the Heinrich-Heine-
Universita ¨t, Du ¨sseldorf. Animals were housed under standard lighting
conditions (normal 12 h/12 h cycle) and provided normal rodent chow
and water ad libitum. Tissue was harvested after euthanasia, using
methods approved under Schedule 1 of the Animals (Scientiﬁc Pro-
cedures) Act 1986. The study was approved by the local University
Review Committee for ethical and safety issues (The investigation also
conforms with the Guide for the Care and Use of Laboratory Animals
published by the US National Institutes of Health, NIH Publication No.
85-23, revised 1996).
2.2 Measurement of vasodilatation using
murine aortic myography
Six to 7-week-old male mice were sacriﬁced by cervical dislocation. The
thoracic aorta from the arch to the diaphragm was removed en bloc and
immediately immersed in ice-cold buffer. Krebs-Henseleit buffer was used
throughout, with the following composition: NaCl 120.0 mM, KCl
4.7 mM, MgSO4 1.2 mM, K2PO4 1.2 mM, Glucose 11.0 mM, CaCl2
2.5 mM,NaHCO325 mM.AllchemicalswereobtainedfromSigma-Aldrich
Co (Gillingham, Dorset, UK), apart from sodium nitrite (Martindale
Pharmaceuticals, Romford, UK) and carboxy-PTIO (Tocris Bioscience,
Bristol, UK). All adherent fat and adventitia was stripped and the endo-
thelium removed by bubbling with air. The aorta was cut into four 2 mm
rings and hung in a four-well wire myograph (Danish Myo Technology
model 610M, A/S, Denmark) in Krebs-Henseleit buffer. Myography wells
were open to the air and bubbled with either carbogen (95% O2/5%
CO2) or nitrogen (N2), with and without carbon monoxide, CO (95%
N2/5% CO2 or 75% N2/5% CO2/20% CO, respectively). Buffer was
allowedtoreachsteadystate.Usingthisequipment,thenitrogen-containing
gas mixtures produced a buffer oxygen tension of 83+2.5 mmHg (11 kPa,
i.e. between average arterial and venous conditions), which was stable over
time. The rings were attached to an isometric force transducer and the
resting tension was increased stepwise to a maximum of 20 mN, which
was determined as optimal in preliminary experiments. A typical trace is
shownin Figure 1A, and a concentration response curve in Figure 1B (carbo-
gen gassing, wild-type aorta, 1 mM phenylephrine precontraction). Prelimi-
nary experiments revealed that the level of constriction achieved using
phenylephrine was variable over different oxygen concentrations, and was
inadequate under reduced oxygen tension (the precontractile tone
achieved using 95% N2/5% CO2 reached  40% of that in the presence of
95%O2/5%CO2).Therefore,50 mMKClwassubstitutedforphenylephrine
forexperimentsperformed undermildly hypoxicconditions. Eachmeasure
wastakenastheaverage of at least two segments and is expressed asa per-
centage reversal of preconstriction. For inhibitor experiments, 50 mM oxy-
purinoland50 nMraloxifenewereincubatedwiththeringsfor5 minbefore
the experimental runs, which were otherwise performed in an identical
fashion. All data are shown as the mean+SEM, and P , 0.05 was taken
to indicate statistical signiﬁcance. Bonferroni post hoc correction was used
for data with multiple comparisons.
2.3 Viral transduction of myoglobin into
myo
2/2 aortic rings
Thoracic aortas from myo
2/2 mice were obtained as before. These rings
were then exposed to either adenovirus expressing myoglobin (AdMYO)
or control virus (AdCtl) (at a concentration of 10
28 PFU/mL) diluted in
Figure 1 Nitrite-dependent vasorelaxation proceeds through liberation of NO. (A) A typical myography trace. (B) A concentration response curve
under typical pharmacological conditions (1 mM phenylephrine constriction, 95% O2)/5% CO2.( C) Addition of 20 mM oxygenated haemoglobin
(oxyHb) or 10 mM 1H-(1,2,4)oxadiazolo(4,3-a)quinoxalin-1-one (ODQ) abolished nitrite-induced vasorelaxation (n ¼ 4 for each group);
**P , 0.001 compared with control by ANOVA. (D) Cyclic GMP (cGMP) accumulation was lower in myo
2/2 tissue than wild type (n ¼ 6 for
each), and was prevented by co-administration of carboxy-PTIO (n ¼ 5); *P , 0.05 compared with control, **P , 0.001 compared with control
and myo
2/2 by ANOVA.
Myoglobin is involved in vasodilation by nitrite 561Opti-MEM (Sigma), supplemented with 11 mM glucose, for 120 min under
continuous bubbling with carbogen gas. Rings were washed with
Opti-MEM to remove adherent virus particles, and then incubated at 378C
in Krebs-Henseleit buffer for 270 min. This incubation time was determined
inpreliminaryexperimentstobesufﬁcientforrecapitulationofthelowlevels
of myoglobin seen in wild-type aorta. Response to nitrite both in the pres-
ence and absence of CO was assessed as before. Nitrite was used at a
ﬁnal concentration of 9 mM ( EC90) in order to focus solely on the effect
of myoglobin (i.e. after saturating other pathways).
2.4 Measurement of cGMP accumulation in
aortic tissue
Fresh aortic tissue was exposed to 10 mM nitrite in Krebs-Henseleit
buffer at 378C for 15 min, with and without the NO scavenger
carboxy-PTIO. A phosphodiesterase inhibitor cocktail was used, as
described previously.
22 cyclic GMP (cGMP) was measured in aortic
tissue after homogenization using a commercial ELISA kit (Amersham
Biotech, UK).
2.5 Generation of replication-defective
adenoviruses
Both AdMyo and AdCtl (control virus) were generated using the AdEasy
XL Adenoviral vector system (Stratagene). Human wild-type myoglobin
cDNA was cloned into the pShuttle-IRES-hrGFP-1 vector (Stratagene),
allowing co-expression of green ﬂuorescent protein (GFP) with myoglo-
bin (a stop codon was introduced to prevent fusion of the FLAG tag).
The vector was linearized by PmeI digestion and recombined with the
pAdEasy-1 (viral backbone vector) in BJ5183 Escherichia coli. The recom-
bined adenoviral constructs were transfected into DH10b E. coli to
allow higher plasmid yields. After conﬁrmation of recombination by
BstXI and Pac-1 restriction digestion and sequencing, Pac1 linearized
recombinant Ad plasmids were then transfected into AD293 cells (Strata-
gene) using oligofectamine (Invitrogen). AD293 cells were scraped from
cell culture vessels and lysed by four freeze-thaw vortex cycles. Lysates
containing recombinant adenoviruses used to infect further AD293 cells
for ampliﬁcation. The viruses were puriﬁed by caesium chloride gradient
ultracentrifugation. The viral titre was estimated by infecting HEK293 cells
(not expressing capsid proteins) and counting GFP expressing cells.
2.6 Endpoint PCR and western blotting
Descending thoracic aortas were removed after euthanasia as above. They
were stripped of all adherent fat and adventitia and snap frozen in liquid
nitrogen. Samples were homogenized using a small blade homogenizer
in TriReagent (Sigma) and RNA was extracted. cDNA was transcribed
from puriﬁed RNA using a standard kit (Applied Biosystems) and 40
cycles of PCR were performed (primer sequences available on request).
Tissue samples for western blotting were snap frozen and subsequently
homogenized in lysis buffer (25 mM Tris/HCl, pH 7.4, 1 mM EDTA, 1%
SDS, 1 mM dithiothreitol, and complete-mini protease inhibitor cocktail
tablet (Roche)) and then boiled with Laemlli buffer. Homogenates were
separated by 15% sodium dodecyl sulphate polyacrylamide gel electro-
phoresis (SDS–PAGE). Proteins were transferred to PVDF membranes
(BioRad), saturated with 5% fat-free milk in 0.1% Tween-20 in phosphate
buffered saline (PBS) (blocking solution), and hybridized with a-myoglobin
rabbit polyclonal antibody (Santa Cruz, (FL-154) sc-25607) at 1:1000
dilution overnight at 48C. The membranes were washed four times
(10 min each at RT) with 0.1% Tween-20 in PBS and then incubated
with goat anti-rabbit IgG (HRP) (Abcam ab2721-1) at 1:4000 dilution
for 1 h at RT, washed four times, and ﬁnally visualized with the ECL
advance immunoblotting detection system (GE Healthcare).
3. Results
3.1 Vasorelaxation with nitrite depends
upon the release of nitric oxide
Nitrite caused concentration-dependent relaxation of endothelium-
denuded aortic rings, which was completely abolished by preincu-
bation with 20 mM oxygenated haemoglobin (oxyHb) (Figure 1C)
implying that nitrite acts through the generation of NO. Moreover,
addition of 10 mM 1H-(1,2,4)oxadiazolo(4,3-a)quinoxalin-1-one
(ODQ) to the organ bath prevented nitrite-induced relaxation
(Figure 1C), suggesting the effects were mediated by stimulation of
soluble guanylyl cyclase. This was conﬁrmed in a separate set of
experiments performed in the presence of a phosphodiesterase
inhibitor cocktail. Under these conditions, the exposure of vascular
tissue to nitrite caused accumulation of cyclic GMP (cGMP), which
was lower in myo
2/2 tissue than in wild type and abolished by pre-
incubation with the NO scavenger, carboxy-PTIO (Figure 1D).
3.2 Vascular myoglobin can mediate
nitrite-dependent vasorelaxation and is
inhibited by carbon monoxide
Acute vasorelaxation induced by increasing concentrations of sodium
nitrite was assessed during exposure to 95% N2/5% CO2 and then to
20% CO/75% N2/5% CO2. The level of CO was chosen to inhibit only
haem proteins, as previously described,
23 and did not in itself cause
vasorelaxation. CO inhibited nitrite-induced vasorelaxation in the
murine wild-type aortas (P , 0.001 by two-way ANOVA)
(Figure 2A) suggesting that an intrinsic vascular haem moiety signiﬁ-
cantly contributes to vascular nitrite bioconversion. The effect of
50 mM oxypurinol (an inhibitor of xanthine oxidase) and 50 nM ralox-
ifene (an inhibitor of aldehyde dehydrogenase) is shown for compari-
son. To assess whether myoglobin was this haem moiety, myo
2/2
mice
24 were compared with wild-type controls. Overall response to
nitrite was markedly reduced in myo
2/2 rings (Figure 2B)( P , 0.001
by two-way ANOVA), implying that myoglobin signiﬁcantly contrib-
utes to vascular nitrite bioconversion. In contrast to wild-type
aortas, CO did not inhibit vasorelaxation in myo
2/2 rings
(Figure 2B). To identify the sources of residual nitrite bioconversion,
we assessed myo
2/2 aortic rings for their vasodilator response to
an informative level of nitrite (9 mM; as derived from the concen-
tration response curve) in our experimental system. Preincubation
time of vascular rings with inhibitors was 5 min with each agent sep-
arately or together; optimal concentrations of inhibitors used were
determined in preliminary experiments. Fifty micromolar oxypurinol
caused a 32% inhibition of vasorelaxation (from 21.3+0.4 to
14.4+1.4%, P , 0.05 by ANOVA) whereas 50nM raloxifene pro-
duced a 32% inhibition (from 21.3+0.4 to 14.3+0.5%, P , 0.05
by ANOVA). The two agents in combination inhibited nitrite-induced
vasodilation by 60% (from 21.3+0.4 to 8.5+1.1%, P , 0.001 by
ANOVA) (Figure 2C).
3.3 Relaxation to sodium nitroprusside is
increased by carbon monoxide in both
wild-type and myo
2/2 rings
Sodium nitroprusside (SNP) was used to assess the effect of CO on
vasorelaxation by a nitrite-independent NO donor. Importantly,
myo
2/2 aortic rings retained their response to NO (i.e. the extent
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parable in tissues from wt and myo
2/2 mice) and relaxation was
increased from 37.7+3.5 to 43.7+4.2% by the addition of CO
(P ¼ 0.032 by ANOVA). In wild-type mice, relaxation was increased
from 42.3+4.7 to 58.7+6.0% (P ¼ 0.029 by ANOVA) (Figure 2D).
The difference in magnitude of effect of CO is consistent with
greater scavenging of NO by myoglobin in the wild-type mouse.
3.4 Viral transduction of myoglobin into
myo
2/2 aortas increases nitrite response
and reverses the response to CO
To conﬁrm the role of myoglobin as a nitrite bioconvertor and to
exclude the possibility that the changes noted in the myo
2/2 mice
were artefactual adaptations to gene manipulation, we investigated
the effect of restoring myoglobin in myo
2/2 mouse vessels. Transduc-
tion of myoglobin augmented the baseline response to nitrite from
28.6+6.5 to 60.7+7.6% (P ¼ 0.024 by ANOVA) (Figure 3A), com-
pared with control virus-treated rings. The pattern of response to
CO was similar. Thus, treatment with control virus did not change
the effect of CO (from 28.6+6.5 to 31.6+7.0%) (Figure 3A). Cru-
cially, viral transduction of myoglobin reinstated the inhibition of
nitrite relaxation by CO seen in wild-type mice (from 60.7+7.6 to
25.8+3.7%, P ¼ 0.014 by ANOVA) (Figure 3A). The concentration
of nitrite ( EC90 at 9 mM) used in this study was chosen to facilitate
accurate determination of the vasorelaxing effect of nitrite and the
potentially subtle effect of interventions. As expected, endpoint
RT–PCR conﬁrmed that myoglobin is present at mRNA level in wild-
type murine aortas and absent in myo
2/2 aortas (Figure 3B). Western
blotting conﬁrmed the presence of myoglobin in AdMYO-treated and
wild-type rings, at a similarly low level, and its absence in AdCtl-
treated rings (Figure 3C).
4. Discussion
In this study, we demonstrate for the ﬁrst time that smooth muscle
myoglobin is an important vascular nitrite reductase. This conclusion
was based on the following observations: (a) vascular bioconversion
of exogenous nitrite is sensitive to CO, and therefore is likely to
depend upon a haem protein; (b) in contrast, in aortic rings from
myoglobin-deleted mice vasorelaxation was unchanged or increased
in the presence of CO, implying that the net contribution of haem
proteins other than myoglobin is NO scavenging; (c) deletion of myo-
globin substantially diminishes exogenous nitrite-mediated vasorelaxa-
tion, indicating that myoglobin is a major bioconvertor of exogenous
nitrite in aortic rings; (d) restitution of myoglobin to myo
2/2 mouse
aortas results in increased vasorelaxation; and restoration of the wild-
type pattern of response to CO (i.e. inhibition of vasorelaxation).
Figure 2 Myoglobin is a major contributor to nitrite-dependent vasorelaxation. (A) Wild-type aorta shows an inhibition of nitrite-dependent vasor-
elaxation in response to CO, n ¼ 5, P , 0.001 by two-way ANOVA. (B) This inhibition with CO is not seen in myo
2/2, n ¼ 5, P ¼ 0.44 by two-way
ANOVA. (C) Conversely, response to sodium nitroprusside is increased by CO in both wild-type and myo
2/2 rings, *P , 0.05 compared with the
same tissue preparation without CO (repeated measures ANOVA). (D) The majority of the remainder of nitrite-dependent vasorelaxation in myo
2/2
aorta is due to xanthine oxidase and aldehyde dehydrogenase, n ¼ 4, *P , 0.05, **P , 0.001 compared with nitrite alone (repeated measures
ANOVA).
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mediated blood vessel relaxation are xanthine oxidase and aldehyde
dehydrogenase.
There is broad consensus that haem proteins may be involved in
vasodilatation by nitrite,
21,25 although the precise contribution of hae-
moglobin is controversial.
13215,17,26,27 Nitrite-induced vasorelaxation
is inhibited by oxyhaemoglobin and, to a lesser extent, by deoxyhae-
moglobin.
17,21,28 There is also increasing evidence that the mechanism
of nitrite-induced vasorelaxation is intrinsic to the vessel.
21,28 From a
chemical perspective, myoglobin is an excellent candidate for an
intrinsic vascular nitrite reductase. First, the nitrite to haem ratio in
vascular smooth muscle is  5000 times greater than in red blood
cells.
27,29,30 Secondly, myoglobin is a more potent reductase at low
pH and at low oxygen tensions (deoxy state Km ¼ 3.1 mM). Finally,
the low haem redox potential of deoxymyoglobin enhances
reductase activity such that it is probably equivalent in this regard
to the R-state of haemoglobin.
27 Nitrite reduction by myoglobin
yields NO and metmyoglobin;
27 metmyoglobin is a relatively inefﬁ-
cient NO scavenger, which allows NO to be liberated. By contrast,
in red blood cells, methemoglobin is both more plentiful and a
more efﬁcient scavenger, which may hinder NO release. Myoglobin
has been shown to be a very important nitrite reductase in the
heart,
20 but myoglobin concentrations are very high in cardiac
muscle, whereas studies in vascular smooth muscle have reported
very low or absent concentrations of myoglobin.
21,31 While we
conﬁrm that the concentration of myoglobin in vascular rings is
very low, we nevertheless demonstrated that it is sufﬁcient to
affect nitrite reductase activity in this model.
Nitrite is present in human plasma at a level of 0.3–
1.0 mM,
26,29,32,33 so the concentrations used in the present study
are clearly supraphysiological. Thus, the results of our investigation
may pertain more to nitrite pharmacology or pathophysiology than
physiological homeostasis. Nonetheless, the potential role of myoglo-
bin in the physiological reduction of nitrite is an exciting avenue for
future research. A relative strength of the present study was that it
was performed at physiological oxygen tension (normoxia to mild
hypoxia). However, our aortic ring studies shed no light on the role
of haemoglobin or the interactions between red blood cells and
vessel walls,
14,17 for example, the extent to which red blood cells sca-
venge or augment NO production by myoglobin, or the contribution
of their S-nitrosothiols to nitrite-induced hypoxic vasodilation.
21,25,28
It is tempting to speculate on a physiological role for this phenom-
enon, as smooth muscle myoglobin is perfectly positioned to sense
and respond to oxygen deﬁciency. In hypoxia, nitrite is a more
potent vasodilator,
2 likely through increased liberation of NO.
Through NO release, oxygen may be conserved by controlling oxi-
dative phosphorylation
34 and by modifying HIF-1a.
4,19,20,35,36 The
same mechanism could also restore tissue oxygenation through
vasodilatation.
2
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Figure 3 Adenovirus-mediated restitution of myoglobin in myo
2/2 mouse aortic rings augments nitrite-dependent vasorelaxation and restores the
inhibitory response to CO. (A) AdMYO-treated aortic rings show increased nitrite-dependent vasorelaxation compared with AdCtl-treated rings,
n ¼ 4 for both, P ¼ 0.024 by ANOVA. Similar to untreated myo
2/2 aorta, AdCtl-treated rings show no decrease in nitrite-dependent vasorelaxation
in response to CO, P ¼ NS by ANOVA. Conversely, AdMYO-treated aortic rings show a diminution of nitrite response when exposed to CO,
P ¼ 0.014 by ANOVA. (B) Myoglobin was present at mRNA level in wild type but not in myo
2/2 aortas; myo
2/2 mice do not adapt to knockout
by upregulation of soluble guanylate cyclase (sGC). Endpoint PCR of cDNA from wild-type control and myo
2/2 aorta, plus wild-type heart positive
control; targets are myoglobin, sGC, and glyceraldehyde-3-phosphate dehydrogenase (GAPDH) as a control. (C) The presence of myoglobin (at a very
low level) was conﬁrmed by western blotting of wild-type and AdMYO-transduced myo
2/2 aortic rings. As expected, control virus-treated (AdCtl)
myo
2/2 rings did not express myoglobin.
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